SavedAdd your journal

Journals / Sakarya Tıp Dergisi / 2018 / Cilt: 8 - Sayı: 2

Microalbuminuria is Not A Risk Factor for Restenosis for Patients with Below The Knee Artery Disease and Critical Limb İschemia Underwent Endovascular Therapy

Mikroalbuminüri, Kritik Uzuv İskemisi Sebebi İle Diz Altı Arterlere Uygulanan Endovasküler Tedavide Restenoz İçin Risk Faktörü Değildir

Süleyman AKTÜRK
Burak TEYMEN
Pages
247–253
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically signifi cant increase in the ABI (MA before 0.45±0.11 vs. after 0.89±0.08 p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective The aim of this study was to determine whether microalbuminuria (MA) is predictive of restenosis in patients with below the knee artery(BTK) disease and treated with endovascular therapy (EVT). ( Sakarya Med J, 2018, 8(2):247-253 )Materials andMethodsWe retrospectively identifi ed patients from May 2012 to September 2016 at our clinic with severely diseased BTK arteries successfullytreated by endovascular approach and measured MA recently before intervention.
📊
Key Findings & Data:All patients had ankle-brachial index (ABI) measuredbefore and after the intervention, and regular clinical follow-up with Duplex ultrasonography performed at 1 month, 6 months and 1 year.Patients underwent peripheral angiography if needed.Results 46 patients with BTK arteries critical stenosis or occlusion treated with endovascular therapy and measurement of MA (through threemonths before intervention) in our institute were included.
💡
Conclusion & Impact:A statistically signifi cant increase in the ABI (MA before 0.45±0.11 vs. after 0.89±0.08 p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective The aim of this study was to determine whether microalbuminuria (MA) is predictive of restenosis in patients with below the knee artery(BTK) disease and treated with endovascular therapy (EVT). ( Sakarya Med J, 2018, 8(2):247-253 )Materials andMethodsWe retrospectively identifi ed patients from May 2012 to September 2016 at our clinic with severely diseased BTK arteries successfullytreated by endovascular approach and measured MA recently before intervention. All patients had ankle-brachial index (ABI) measuredbefore and after the intervention, and regular clinical follow-up with Duplex ultrasonography performed at 1 month, 6 months and 1 year.Patients underwent peripheral angiography if needed.Results 46 patients with BTK arteries critical stenosis or occlusion treated with endovascular therapy and measurement of MA (through threemonths before intervention) in our institute were included. Patients were divided into two groups with MA and normoalbuminuria (MANS).There were 8 restenosis in the MA group (63.6% patency rate) and 5 restenosis in the MANS group (77.3 % patency rate) at 1 year(p=0.517). A statistically signifi cant increase in the ABI (MA before 0.45±0.11 vs. after 0.89±0.08 p

Özet

Amaç Bu çalışmanın amacı mikroalbuminürinin dizaltı arterler hastalığı olan hastalara yapılan endovasküler girişim tedavisi sonrası restenozda öngörüsel olup olmadığıdır. ( Sakarya Tıp Dergisi, 2018, 8(2):247-253 ). Gereç ve Yöntem Çalışmamıza retrospektif olarak Mayıs 2012 ve Eylül 2016 tarihleri arasında dizaltı arterlerinde ciddi darlık veya tıkanıklıkları olan ve başarılı olarak endovasküler yöntem ile tedavi edilmiş ve yakın zaman içinde mikroalbuminüri (MA) değerleri ölçülmüş hastalar tanımlandı. Bütün hastalarda işlem öncesi ve sonrası ayak bileği/brakiyal indeks (ABI) değerlendirilmek ile birlikte, düzenli klinik takipte 1, 6, ve 12. Ayda duplex ultrasonları yapıldı. Ultrason sonuçlarına göre gerekli görülen hastalarda periferik anjiyografi yapıldı. Results Kliniğimizde dizaltı arterlerinde ciddi darlığı veya tıkanıklığı olan ve mikroalbuminürisi ölçülmüş (işlemden 3 ay öncesine kadar sürede) endovasküler yaklaşım ile tedavisi yapılmış 46 hasta çalışmaya dahil edildi. Hastalar mikroalbuminürisi olup olmamasına göre 2 gruba ayrıldı (MA grup, MANS=mikroalbuminüri olmayan grup). MA grubunda 8 restenoz (63.6 % primer açık kalım oranı), MANS grubunda 5 restenoz (77.3 % primer açık kalım oranı) gözlendi. ABI’ de iki grupta da istatistiksel olarak önemli artış görülmek ile birlikte (MA işlem öncesi 0.45±0.11, işlem sonrası 0.89±0.08 p

🔖

Cite This Article

AKTÜRK, S., TEYMEN, B. (2022). Microalbuminuria is Not A Risk Factor for Restenosis for Patients with Below The Knee Artery Disease and Critical Limb İschemia Underwent Endovascular Therapy. Sakarya Tıp Dergisi, Cilt: 8 - Sayı: 2, 247–253. https://ajindex.com/articles/590453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003; 163:884 – 892
  2. M.H. Criqui, V. Aboyans. Epidemiology of peripheral artery disease, Circ. Res. 116 2015 1509–1526
  3. U. Baber, D. Mann, D. Shimbo, M. Woodward, J.W. Olin, P. Muntner, Combined role of reduced estimated glomerular fi ltration rate and microalbuminuria on the prevalence of peripheral arterial disease, Am. J. Cardiol. 104 2009 1446–1451
  4. Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009;50:1462–73
  5. Cao JJ, Barzilay JI, Peterson D, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 2006;187:372e7
  6. Baber U1, Mann D, Shimbo D, Woodward M, Olin JW, Muntner P. Combined role of reduced estimated glomerular fi ltration rate and microalbuminuria on the prevalence of peripheral arterial disease. Am J Cardiol. 2009 Nov 15;104(10):1446-51
  7. TASC Steering Committee, Jaff MR1, White CJ2, Hiatt WR3, Fowkes GR4, Dormandy J5, Razavi M6, et al. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classifi cation to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Endovasc Ther. 2015 Oct;22(5):663-77. doi: 10.1177/1526602815592206. Epub 2015 Aug 3
  8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifi cation, and stratifi cation. Am J Kidney Dis 2002;39:S1–S266
  9. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421e6 10. Mykkanen L, Zaccaro DJ, O’Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997;28:1710 –1716
  10. Stehouwer CDA: Endothelial dysfunction in diabetic nephropathy: state of the art and potential signifi cance for non-diabetic renal disease. Nephrol Dial Transplant 2004; 19: 778–781
  11. Schmidt A, Ulrich M, Winkler B, Klaef ing C, Bausback Y, Bräunlich